MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis

Parasitology

Volumn 128, Issue 4, 2004, Pages 397-405

  Roque ReseNdiz J L ^a   Rosales, R ^a,b   Herion, P ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

MVA; Toxoplasmosis; Vaccinia virus

Indexed keywords

DNA VACCINE; PROTEIN; PROTEIN ROP2; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CAT; CONTROLLED STUDY; EMBRYO; FEMALE; GENE; GENE EXPRESSION; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; ROP2 GENE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; BRAIN; CHICK EMBRYO; DNA, PROTOZOAN; DNA, RECOMBINANT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA; VACCINIA VIRUS;

ANIMALIA; CAPRA HIRCUS; FELIS CATUS; HERPESVIRIDAE; OVIS ARIES; PROTOZOA; TOXOPLASMA GONDII; VACCINIA VIRUS;

EID: 2442492088     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182003004761     Document Type: Article

References (29)

1. AMARA, R., VILLINGER, F., STAPRANS, S. I., ALTMAN, J. D., MONTEFIORI, D. C., KOZYR, N. L., NU, Y., WYATT, L. S., EARL, P. L., HERNDON, J. G., MCCLURE, H. M., MOSS, B. & ROBINSON, H. L. (2002). Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.9P mucosal challenge by modified vaccinia virus ankara (MVA) and DNA/MVA vaccines. Journal of Virology 76, 7625-7631.
2. ANGUS, C. W., KLIVINGTON-EVANS, D., DUBEY, J. P. & KOVACS, J. A. (2000). Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. Journal of Infectious Diseases 181, 317-324.
3. BHOPALE, G. M. (2003). Development of a vaccine for toxoplasmosis. Current status. Microbes and Infection 5, 457-462.
4. BINNS, M. M. & SMITH, G. L. (1993). Recombinant Poxvirus. ACR Press, Boca Raton, Florida.
5. CANN, A. J. (1997). Principles of Molecular Virology. Academic Press, San Diego.
6. COUPER, K. N., NIELSEN, H. V., ESKILD, P., ROBERTS, F., ROBERTS, C. W. & ALEXANDER, J. (2003). DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 21, 2813-2820.
7. COUVREUR, G., SADAK, A., FORTIER, B. & DUBREMETZ, J. F. (1988). Surface antigens of Toxoplasma gondii. Parasitology 97, 1-10.
8. FACHADO, A., RODRIGUEZ, A., MOLINA, J., SILVÉRIO, J., MARINO, A., PINTO, L., ANGEL, S., INFANTE, J., TRAUB-CSEKO, Y., AMENDOEIRA, R. & LANNES-VIEIRA, J. (2003). Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii. Infection and Immunity 71, 5407-5411.
9. FATOOHI, A. F., COZON, G. J. N., GREENLAND, T., FERRANDIZ, J., BIENVENUE, J., PICOT, S. & PEYRON, F. (2002). Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clinical and Diagnostic Laboratory Immunology 9, 704-707.
10. FENNER, F., HENDERSON, D. A., ARITA, I., JEZEK, Z. & LADNYI, I. D. (1988). Smallpox and its Erradication. WHO: Geneva.
11. FRANCOISE, J., JADIN, J., WERY, M. & VAN DE CASTEELE, J. (1963). Etude expérimentale du traitement de la toxoplasmose. Bulletin Academic Research Medical 7, 459-485.
12. GAZZINELLI, R., XU, Y., HIENY, S., CHEEVER, A. & SHER, A. (1992). Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Journal of Immunology 149, 175-180.
13. HAUMONT, M., DELHAYE, L., GARCIA, L., JURADO, M., MAZZA, P., DAMINET, V., VERLANT, V., BOLLEN, A., BIEMANS, R. & JACQUET, A. (2000). Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infection and Immunity 68, 4948-4953.
14. JACKSON, M. H. & HUTCHISON, W. M. (1989). The prevalence and source of Toxoplasma infection in the environment. Advances in Parasitology 28, 55-105.
15. KUZNETSOV, V. A., MAKALKIN, I. A., TAYLOR, M. A. & PERELSON, A. S. (1994). Non-linear dymamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bulletin of Mathematical Biology 56, 295-321.
16. LEVINE, A. J. (1994). The origins of the small DNA tumor viruses. Advances in Cancer Research 55, 150-158.
17. LEYVA, R., HERION, P. & SAAVEDRA, R. (2001). Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research 87, 70-79.
18. LUNDE, M. N. & JACOBS, L. (1983). Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. Journal of Parasitology 69, 806-808.
19. MISHIMA, M., XUAN, X., YOKOYAMA, N., IGARASHI, I., FUJISAKI, K., NAGASAWA, I. & MIKAMI, T. (2002). Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitology Research 88, 144-149.
20. MONTOYA, J. G., LOWE, K. E., CLAYBERGER, C., MOODY, D., DO, D., REMINGTON, S., TALIB, S. & SUBAUSTE, C. S. (1996). Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii infected cells. Infection Immunology 64, 176-181.
21. PELLOUX, H., WEISS, J., SIMON, J., MUET, F., FRICKER-HIDALGO, H., GOULLIER-FLEURET, A. & AMBROISE-THOMAS, P. (1996). A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction. FEMS Microbiology Letters 138, 11-15.
22. PFEFFERKORN, E. R. & PFEFFERKORN, L. C. (1976), Toxoplasma gondii isolation and preliminary characterization of temperature-sensitive mutants. Experimental Parasitology 39, 365-376.
23. SAAVEDRA, R., BECERRIL, M., DUBEAUX, C., LIPPENS, R., DE VOS, M.-J., HERION, P. & BOLLEN, A. (1996). Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infection and Immunity 64, 3858-3862.
24. SABIN, A. B. (1941). Toxoplasmic encephalitis in children. Journal of the American Medical Association 116, 801.
25. SADAK, A., TAGHY, Z., FORTIER, B. & DUBREMETZ, J.-F. (1988). Characterization of a family of rhoptry proteins of Toxoplasma gondii. Molecular and Biochemical Parasitology 29, 203-211.
26. SUBAUSTE, C. S., KONIARIS, A. H. & REMINGTON, J. S. (1991). Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii infected cells. Journal of Immunology 147, 3955-3959.
27. SUTTER, G. & MOSS, B. (1992). Non replicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Sciences, USA 89, 10847-10851.
28. THOMAS, P. A. (2001). Parasitic diseases and immunodeficiencies. Parasitology 122, S65-S71.
29. VAUADEZ, G., SUTTER, G., JOSE, M., GARCÍA-CARRANCA, A., ERFLE, V., MORENO, M., MERCHANT, H. & ROSALES, R. (2000). Human tumor growth is inhibited by vaccinia virus carrying the E2 gene of bovine papillomavirus. Cancer 88, 1650.